Skip to content
OmniaBio Full Color Logo

Learn more about our CDMO facilities

  • Expertise
    • Cell & Gene Therapy Expertise
    • Immunotherapy
    • LVV
    • iPSC
  • Services
    • Cell & Gene Therapy Services Overview
    • Process Development
    • Analytical Development
    • Commercial Manufacturing
    • GMP Manufacturing
    • Autologous Cell Therapy Manufacturing
    • Cell Banking
    • Regulatory Guidance
    • Supply Chain Security
  • About
    • Overview
    • Facilities
    • Leadership
    • Careers
  • Resource Centre
    • Posters
    • Blog
    • Webinars
    • Videos
  • Media & Events
    • Press Releases
    • OmniaBio in the News
    • Events
  • Contact
OmniaBio Full Color Logo

Learn more about our CDMO facilities

  • Expertise
    • Cell & Gene Therapy Expertise
    • Immunotherapy
    • LVV
    • iPSC
  • Services
    • Cell & Gene Therapy Services Overview
    • Process Development
    • Analytical Development
    • Commercial Manufacturing
    • GMP Manufacturing
    • Autologous Cell Therapy Manufacturing
    • Cell Banking
    • Regulatory Guidance
    • Supply Chain Security
  • About
    • Overview
    • Facilities
    • Leadership
    • Careers
  • Resource Centre
    • Posters
    • Blog
    • Webinars
    • Videos
  • Media & Events
    • Press Releases
    • OmniaBio in the News
    • Events
  • Contact

Regulatory Guidance Throughout Your CMC Journey

Our specialized knowledge in CGT regulatory affairs can help de-risk projects at any stage of development. With experience working with regulators around the world, we can deliver customized go-to-market cell therapy regulatory guidance and strategies.

Integrated Help at Every Step

We offer a full suite of cell therapy regulatory guidance consultation:

  • Interpretation and explanation of regulatory context
  • Assistance in developing regulatory plans to drive the commercialization strategy
  • Reduction of regulatory unknowns in project planning
  • Guidance and support throughout the preparation and submission process, including leading interactions with regulators such as US FDA and Health Canada
  • Regulatory support for manufacturing under GMP, including drafting and reviewing CMC sections of the regulatory submission

A Successful Track Record of Compliance

Powered by CCRM, we have a proven track record of navigating the regulatory landscape. We do so by working as an extension of your team. Our comprehensive regulatory plans identify efficiencies in time and resources, leading to the best outcome as fast as possible.

Get Your Products To Patients
Regulatory Support Track Record photo of vials

Featured Webinar Transcript

iPSC-based Therapy Dilemmas Explored: Overcoming Hurdles For Future Success

Learn from industry experts as they delve into the critical aspects of reshaping the future landscape of iPSC-based therapies.

Read the Transcript

Support in Every Area of Expertise

Immunotherapy

Immunotherapy Icon

Best-in-class solutions for cell therapy development and manufacturing

Learn more about Immunotherapy

Lentiviral Vectors

Lentiviral Vectors Icon

Enhancing gene delivery through end-to-end developmental support

Learn more about
Lentiviral Vectors

iPSC

iPSC Icon

Industry-leading experience and capabilities in stem cell based therapies

Learn more
about iPSC

Contact Us

Get your Product to Approval
OmniaBio Footer Logo in Full Color

© 2025 OmniaBio   |   Privacy Policy

  • Expertise
    • Cell & Gene Therapy Expertise
    • Immunotherapy
    • LVV
    • iPSC
  • Services
    • Cell & Gene Therapy Services Overview
    • Process Development
    • Analytical Development
    • Commercial Manufacturing
    • GMP Manufacturing
    • Autologous Cell Therapy Manufacturing
    • Cell Banking
    • Regulatory Guidance
    • Supply Chain Security
  • About
    • Overview
    • Facilities
    • Leadership
    • Careers
  • Resource Centre
    • Posters
    • Blog
    • Webinars
    • Videos
  • Media & Events
    • Press Releases
    • OmniaBio in the News
    • Events
Contact Us
Scroll to Top